Elliot M. Maza

Biography

  Elliot M. Maza, J.D, CPA has been appointed as Interim Chief Executive Officer, Director of Immune Pharmaceuticals Inc., effective April 24, 2017. He became a director of the Company on January 14, 2015. From November 2014 to January 2015, Mr. Maza served as a consultant to the Company. Mr. Maza has been the Chairman of the Board of Directors, Chief Executive Officer and Chief Financial Officer of Intellect Neurosciences, Inc., a biotechnology company focused on the development of therapeutics neurodegenerative diseases, since July 2014. From May 2006 to June 2014, Mr. Maza served in several management positions at Intellect Neurosciences, Inc., including, Executive Vice President from May 2006 to March 2007, President from March 2007 to October 2011, Chief Financial Officer from May 2006 to the present and member of the Board of Directors since June 2007. Mr. Maza served as Chief Executive Officer, Chief Financial Officer and member of the Board of Directors of Biozone Pharmaceuticals, Inc., a contract manufacturer of prescription and over-the-counter (OTC) drug products and anti-aging and skin care products, from July 2011 until January 2014. From December 2003 to May 2006, Mr. Maza served as Chief Financial Officer of Emisphere Technologies, Inc., a biopharmaceutical company specializing in oral drug delivery. From March 1999 to December 2003, Mr. Maza was a partner at Ernst and Young, LLP. During the period from May 1989 to March 1999, Mr. Maza served as an Associate and subsequently Vice President in the Fixed Income divisions of Goldman Sachs, Inc. and JP Morgan Securities, Inc. Mr. Maza practiced law at Sullivan and Cromwell in New York from September 1985 to April 1989. We believe that Mr. Maza is qualified to serve as the Interim Chief Executive Officer and director of the Company based on his experience as a senior executive in several biotech and biopharma companies.

Research Interest

 finance business and management